Regulation of VEGF expression in human retinal cells by cytokines: Implications for the role of inflammation in age‐related macular degeneration
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Chronic inflammation is implicated in the pathogenesis of age‐related macular degeneration (AMD). Choroidal neovascularization (CNV) observed in exudative form of AMD results in vision loss. Human retinal pigment epithelial cell (HRPE) layer and choroidal tissue are the primary pathological sites in AMD. Pathological and therapeutic evidences have strongly indicated the vascular endothelial growth factor (VEGF) molecules as critical components in CNV pathogenesis. In these studies, we used human primary HRPE and choroidal fibroblast cells (HCHF) prepared from adult donor eyes. The effects of inflammatory cytokine (IFN‐γ + TNF‐α + IL‐1β) mix (ICM) on global gene expression profiles in HRPE cells, revealed 10‐ and 9‐fold increase in VEGF‐A and VEGF‐C expression, respectively. The microarray results were validated by quantitative RT‐PCR and secretion of VEGFs proteins. IL‐1β is the most potent in inducing VEGFs secretion followed by IFN‐γ and TNF‐α, and the secretion was more effective in the presence of 2 and 3 cytokines. NF‐κB and JAK‐STAT pathway, but not HIF‐1α, Sp‐1, Sp‐3, and STAT‐3, transcription factors were upregulated and translocated to nucleus by ICM treatment. The mRNA levels of VEGF‐A and VEGF‐C and secretion of these proteins were also significantly enhanced by ICM in HCHF cells. The secretion of other angiogenic molecules, PEDF, SDF‐1α, endostatin, and angiopoietins was not affected by ICM. Our results show that the inflammatory cytokines enhance secretion of VEGF‐A and VEGF‐C by HRPE and HCHF cells. These studies indicate that VEGFs secreted by these cells initiate and promote pathological choroidal and retinal noevascularization processes in AMD. J. Cell. Physiol. 227: 116–126, 2012. © 2011 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424 · cited 1×
“More recently, genetic polymorphism in compliment factor H, a complement-inactivating factor, confirmed a strong inflammation association with AMD (Hageman et al., 2005; Haines et al., 2005).”
BackgroundHageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961 · cited 2×
“More recently, genetic polymorphism in compliment factor H, a complement-inactivating factor, confirmed a strong inflammation association with AMD (Hageman et al., 2005; Haines et al., 2005).”
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265 · cited 3×
“…clinico-pathological, epidemiological, and gene mapping studies indicate a strong association of inflammatory processes in the initiation and/or progression of AMD (Hageman et al., 2001; Anderson et al., 2002; Bok, 2005; Donoso et al., 2006; Nussenblatt and Ferris, 2007; Swaroopet al., 2009).”
BackgroundCurrent concepts in the pathogenesis of age-related macular degeneration
Zarbin, M. A. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.598 · Cited by 1,006 · cited 6×
“In thewet formof AMD,more serious condition of the disease, CNVmay develop and this results in growth of new blood vessels (Ambati et al., 2003; Das and McGuire, 2003; JOURNAL OF CELLULAR PHYSIOLOGY I N F L A M M A T I O N A N D V E G F I N A M D 123 Zarbin, 2004; Swaroop et al., 2009).”
BackgroundInfluentialAge-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959 · cited 11×
“Because AMD may take years or decades to develop, it is difficult to follow the precise disease pattern and etiology (Ambati et al., 2003; Klein et al., 2007; Swaroop et al., 2009).”
BackgroundInfluentialDrusen complement components C3a and C5a promote choroidal neovascularization
Nozaki, M., Raisler, B. J., Sakurai, E., Sarma, J. V., Barnum, S. R., Lambris, J. D., Chen, Y., Zhang, K., Ambati, B. K., Baffi, J. Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408835103 · Cited by 650
Immunological and Aetiological Aspects of Macular Degeneration
Penfold, P. L., Madigan, M. C., Gillies, M. C., & Provis, J. M. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(00)00025-2 · Cited by 460 · cited 9×
“…vessels and/or abnormal and unwanted growth of blood vessels, as in many tumors and other neovascularization JOURNAL OF CELLULAR PHYSIOLOGY 124 N A G I N E N I E T A L . disorders such as CNV in AMD (Ambati et al., 2003; Das and McGuire, 2003; Campochiaro, 2004; Zarbin, 2004; Penn et al., 2008).”
BackgroundInfluentialAssociation between C-reactive protein and age-related macular degeneration
Seddon, J. M. (2004) · JAMA · doi:10.1001/jama.291.6.704 · Cited by 376
Cao, R., Eriksson, A., Kubo, H., Alitalo, K., Cao, Y., & Thyberg, J. (2004) · Circulation Research · doi:10.1161/01.res.0000118600.91698.bb · Cited by 324
Bhutto, I. A., McLeod, D. S., Hasegawa, T., Kim, S. Y., Merges, C., Tong, P., & Lutty, G. A. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.05.007 · Cited by 275 · cited 2×
“…correlate with CNV activity in AMD (Bressler et al., 1994; Cousins et al., 2004; Grossniklaus et al., 2005), andVEGF stainingwasmore in RPE than in the infiltrating cells in these cases (Amin et al., 1994; Lopez et al., 1996; Kliffen et al., 1997; Grossniklaus et al., 2002; Bhutto et al., 2006).”
BackgroundSwaroop, A., Chew, E. Y., Bowes Rickman, C., & Abecasis, G. R. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164350 · Cited by 270
BRESSLER, N. M., SILVA, J. C., BRESSLER, S. B., FINE, S. L., & GREEN, W. R. (1994) · Retina · doi:10.1097/00006982-199414020-00006 · Cited by 200
Age-related macular degeneration and the immune response: implications for therapy
Nussenblatt, R. B., & Ferris, F. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.025 · Cited by 130 · cited 1×
“In active CNV stage, more inflammatory cells such as macrophages and lymphocytes were detected (Penfold et al., 2001).”
Background
Cited by
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Lee, C., Kim, M.-J., Kumar, A., Lee, H.-W., Yang, Y., & Kim, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02249-0 · Cited by 365
The Role of Inflammation in Age-Related Macular Degeneration
Tan, W., Zou, J., Yoshida, S., Jiang, B., & Zhou, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.49890 · Cited by 311
The tspo-nox1 axis controls phagocyte-triggered pathological angiogenesis in the eye
Wolf, A., Herb, M., Schramm, M., & Langmann, T. (2020) · Nature Communications · doi:10.1038/s41467-020-16400-8 · Cited by 80
Jackson, T. L., Slakter, J., Buyse, M., Wang, K., Dugel, P. U., Wykoff, C. C., Boyer, D. S., Gerometta, M., Baldwin, M. E., Price, C. F., et al. (2023) · Ophthalmology · doi:10.1016/j.ophtha.2023.02.001 · Cited by 55
Metadata
- Authors
- Nagineni, C. N., Kommineni, V. K., William, A., Detrick, B., & Hooks, J. J.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2011-10-24
- Volume
- 227
- Issue
- 1
- Pages
- 116-126
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2085733337
- Cited by
- 150
- References
- 14
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.